1. Home
  2. Analysis

Urinary tract infection and drugs of ingredients of vitamin b12 - a phase IV clinical study of FDA data


Summary:

Urinary tract infection is found among people who take drugs with ingredients of vitamin b12, especially for people who are female, 60+ old , have been taking the drugs for 6 - 12 months. This phase IV clinical study is created by eHealthMe based on reports of 2,682 people who have side effects when taking drugs with ingredients of vitamin b12 from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): B complex vitamin, B-12, B12, Bedumil, Cobalamin, Cobamin, Cyanocobalaminum, Cycobemin, Hydroxocobalaminum, Hydroxocobemine, Idrossocobalamina, Methylcobalamin, Vitadurin.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

2,682 people reported to have side effects when taking drugs with ingredients of vitamin b12.
Among them, 68 people (2.54%) have Urinary tract infection

What is Urinary tract infection?

Urinary tract infection is found to be associated with 4,051 drugs and 3,738 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of vitamin b12 cause Urinary tract infection?

Time on drugs with ingredients of vitamin b12 when people have Urinary tract infection *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Urinary tract infection when taking drugs with ingredients of vitamin b12 *:

  • female: 85.25 %
  • male: 14.75 %

Age of people who have Urinary tract infection when taking drugs with ingredients of vitamin b12 *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.08 %
  • 20-29: 6.25 %
  • 30-39: 2.08 %
  • 40-49: 10.42 %
  • 50-59: 20.83 %
  • 60+: 58.33 %

Conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 20.59%
  2. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 11 people, 16.18%
  3. Pain: 8 people, 11.76%
  4. High Blood Pressure: 7 people, 10.29%
  5. Metastases To Spine (cancer spreads to spine): 6 people, 8.82%
  6. Neoplasm Malignant (cancer tumour): 6 people, 8.82%
  7. Depression: 6 people, 8.82%
  8. Lung Neoplasm (tumour of lung): 6 people, 8.82%
  9. Calcium Deficiency (lack of calcium): 6 people, 8.82%
  10. Insomnia (sleeplessness): 5 people, 7.35%

Other drugs people take *:

  1. Zofran: 16 people, 23.53%
  2. Tylenol: 15 people, 22.06%
  3. Prednisone: 14 people, 20.59%
  4. Aspirin: 13 people, 19.12%
  5. Zometa: 12 people, 17.65%
  6. Arava: 11 people, 16.18%
  7. Vioxx: 11 people, 16.18%
  8. Enbrel: 11 people, 16.18%
  9. Albuterol: 10 people, 14.71%
  10. Synthroid: 10 people, 14.71%

Other side effects people have besides Urinary tract infection *:

  1. Stress And Anxiety: 18 people, 26.47%
  2. Weakness: 17 people, 25.00%
  3. High Blood Pressure: 17 people, 25.00%
  4. Headache (pain in head): 17 people, 25.00%
  5. Pain: 17 people, 25.00%
  6. Joint Pain: 17 people, 25.00%
  7. Pneumonia: 15 people, 22.06%
  8. Fever: 14 people, 20.59%
  9. Breathing Difficulty: 13 people, 19.12%
  10. Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 17.65%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of vitamin b12, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on vitamin b12. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.